BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19407573)

  • 21. Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan.
    Harano K; Hirakawa A; Kato T; Suzuki K; Watanabe S; Katsumata N
    J Gynecol Oncol; 2014 Apr; 25(2):124-9. PubMed ID: 24761216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative dose intensity as a proxy measure of quality and prognosis in adjuvant chemotherapy for breast cancer in daily clinical practice.
    Schraa SJ; Frerichs KA; Agterof MJ; Hunting JCB; Los M; de Jong PC
    Eur J Cancer; 2017 Jul; 79():152-157. PubMed ID: 28494406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH;
    Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
    Minisini A; Spazzapan S; Crivellari D; Aapro M; Biganzoli L
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):125-31. PubMed ID: 15661563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
    Smith TJ; Khatcheressian J; Lyman GH; Ozer H; Armitage JO; Balducci L; Bennett CL; Cantor SB; Crawford J; Cross SJ; Demetri G; Desch CE; Pizzo PA; Schiffer CA; Schwartzberg L; Somerfield MR; Somlo G; Wade JC; Wade JL; Winn RJ; Wozniak AJ; Wolff AC
    J Clin Oncol; 2006 Jul; 24(19):3187-205. PubMed ID: 16682719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing women's cancer care: highlights from the Annual Meeting on Women's Cancer 2007. Report on the 38th Annual Meeting of the Society of Gynecologic Oncologists, San Diego, Calif., March 3-7, 2007.
    Petignat P; Gotlieb W
    Gynakol Geburtshilfliche Rundsch; 2007; 47(4):240-2. PubMed ID: 17914271
    [No Abstract]   [Full Text] [Related]  

  • 27. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
    Johnston EM; Crawford J
    Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
    Stewart SL; Townsend JS; Puckett MC; Rim SH
    J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
    McCune JS; Sullivan SD; Blough DK; Clarke L; McDermott C; Malin J; Ramsey S
    Pharmacotherapy; 2012 Jan; 32(1):7-19. PubMed ID: 22392824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of granulocyte colony-stimulating factor (G-CSF) in clinical practice in Fukuoka City area in Japan.
    Tamura K
    Fukuoka Igaku Zasshi; 1999 Jun; 90(6):279-85. PubMed ID: 10423924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Recovery After Surgery for Suspected Ovarian Malignancy: A Survey of Perioperative Practice Among Gynecologic Oncologists in Australia and New Zealand to Inform a Clinical Trial.
    Lindemann K; Kok PS; Stockler M; Sykes P; Brand A
    Int J Gynecol Cancer; 2017 Jun; 27(5):1046-1050. PubMed ID: 28525497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management.
    Chen L; Learman LA; Weinberg V; Powell CB
    Int J Gynecol Cancer; 2004; 14(6):1055-62. PubMed ID: 15571610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
    Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):383-387. PubMed ID: 28871988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
    Timmermans M; Sonke GS; van Driel WJ; Lalisang RI; Ottevanger PB; de Kroon CD; Van de Vijver KK; van der Aa MA; Kruitwagen RF
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():98-102. PubMed ID: 29525755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region.
    Trotta F; Mayer F; Mecozzi A; Amato L; Addis A
    BioDrugs; 2017 Apr; 31(2):117-124. PubMed ID: 28353170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey.
    Ferrandina G; Amadio G; Paris I; Distefano M; Palluzzi E; de Vincenzo R; Ricci C; Scambia G
    Int J Gynecol Cancer; 2017 Jul; 27(6):1141-1148. PubMed ID: 28574933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
    Gridelli C; Aapro MS; Barni S; Beretta GD; Colucci G; Daniele B; Del Mastro L; Di Maio M; De Petris L; Perrone F; Thatcher N; De Marinis F
    Crit Rev Oncol Hematol; 2007 Jul; 63(1):53-64. PubMed ID: 17368037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis.
    Martino MA; Williamson E; Rajaram L; Lancaster JM; Hoffman MS; Maxwell GL; Clarke-Pearson DL
    Gynecol Oncol; 2007 Sep; 106(3):439-45. PubMed ID: 17599396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of colony-stimulating factors in acute leukemia.
    Holdsworth MT; Mathew P
    Ann Pharmacother; 2001 Jan; 35(1):92-108. PubMed ID: 11197591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M; Ganser A
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.